Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Somatostatin receptor type 4 is a kind of neurohormone with a wide range of functions. Its main function is to inhibit the basic secretion of pituitary growth hormone (GH), and also to inhibit the GH secretion response caused by various stimuli, including exercise, eating, stress, hypoglycemia, etc. Somatostatin receptor type 4 binds to the membrane receptor of adenohypophysial auxin cells and can play a role by reducing intracellular cAMP and Ca2.
During the forecast period, the global somatostatin receptor type 4 market is expected to achieve modest growth and achieve a compound annual growth rate. The global somatostatin receptor type 4 market can be divided into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by region. North America will continue to dominate the growth of the global somatostatin receptor type 4 market.
In recent years, the increasing incidence of Alzheimer's disease, cognitive disorders, neuroendocrine tumors and acromegaly has greatly stimulated the market demand for somatostatin receptor type 4. In addition, technological advances and supportive government policies will continue to drive the growth of the global somatostatin receptor type 4 market.
The report details the trend, potential and market size of Somatostatin Receptor Type 4 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Somatostatin Receptor Type 4market, defines the market attractiveness level of Somatostatin Receptor Type 4 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Somatostatin Receptor Type 4 industry, describes the types of Somatostatin Receptor Type 4 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Somatostatin Receptor Type 4 market and the development prospects and opportunities of Somatostatin Receptor Type 4 industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Somatostatin Receptor Type 4 market in Chapter 13.
By Player:
Strongbridge Biopharma plc
Crinetics Pharmaceuticals Inc
By Type:
CNTX-0290
NNC-26910
Others
By End-User:
Alzheimer's Disease
Cognitive Disorders
Neuroendocrine Tumors
Acromegaly
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Somatostatin Receptor Type 4 Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Somatostatin Receptor Type 4 Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Somatostatin Receptor Type 4 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Somatostatin Receptor Type 4 Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Somatostatin Receptor Type 4 Market Analysis and Outlook to 2022
-
7.1 Global Somatostatin Receptor Type 4 Consumption (2017-2022)
-
7.2 United States Somatostatin Receptor Type 4 Consumption (2017-2022)
-
7.3 Europe Somatostatin Receptor Type 4 Consumption (2017-2022)
-
7.4 China Somatostatin Receptor Type 4 Consumption (2017-2022)
-
7.5 Japan Somatostatin Receptor Type 4 Consumption (2017-2022)
-
7.6 India Somatostatin Receptor Type 4 Consumption (2017-2022)
-
7.7 South Korea Somatostatin Receptor Type 4 Consumption (2017-2022)
8 Region and Country-wise Somatostatin Receptor Type 4 Market Analysis and Outlook to 2028
-
8.1 Global Somatostatin Receptor Type 4 Consumption Forecast (2022-2028)
-
8.2 United States Somatostatin Receptor Type 4 Consumption Forecast (2022-2028)
-
8.3 Europe Somatostatin Receptor Type 4 Consumption Forecast (2022-2028)
-
8.4 China Somatostatin Receptor Type 4 Consumption Forecast (2022-2028)
-
8.5 Japan Somatostatin Receptor Type 4 Consumption Forecast (2022-2028)
-
8.6 India Somatostatin Receptor Type 4 Consumption Forecast (2022-2028)
-
8.7 South Korea Somatostatin Receptor Type 4 Consumption Forecast (2022-2028)
9 Global Somatostatin Receptor Type 4 Market Outlook by Types and Applications to 2022
-
9.1 Global Somatostatin Receptor Type 4 Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global CNTX-0290 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global NNC-26910 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Somatostatin Receptor Type 4 Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cognitive Disorders Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Neuroendocrine Tumors Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Acromegaly Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Somatostatin Receptor Type 4 Market Outlook by Types and Applications to 2028
-
10.1 Global Somatostatin Receptor Type 4 Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global CNTX-0290 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global NNC-26910 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Somatostatin Receptor Type 4 Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cognitive Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Neuroendocrine Tumors Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Acromegaly Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Somatostatin Receptor Type 4 Import and Export Analysis (Top 5 Countries)
-
11.1 Global Somatostatin Receptor Type 4 Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Somatostatin Receptor Type 4 Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Somatostatin Receptor Type 4 Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Somatostatin Receptor Type 4 Market Competitive Analysis
-
14.1 Strongbridge Biopharma plc
-
14.1.1 Strongbridge Biopharma plc Company Details
-
14.1.2 Strongbridge Biopharma plc Somatostatin Receptor Type 4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Strongbridge Biopharma plc Somatostatin Receptor Type 4 Product and Service
-
14.2 Crinetics Pharmaceuticals Inc
-
14.2.1 Crinetics Pharmaceuticals Inc Company Details
-
14.2.2 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 4 Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Somatostatin Receptor Type 4
-
Figure Somatostatin Receptor Type 4 Picture
-
Table Global Somatostatin Receptor Type 4 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Somatostatin Receptor Type 4 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Somatostatin Receptor Type 4 Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Somatostatin Receptor Type 4 Consumption by Country (2017-2022)
-
Figure United States Somatostatin Receptor Type 4 Consumption and Growth Rate (2017-2022)
-
Table Europe Somatostatin Receptor Type 4 Consumption and Growth Rate (2017-2022)
-
Figure China Somatostatin Receptor Type 4 Consumption and Growth Rate (2017-2022)
-
Figure Japan Somatostatin Receptor Type 4 Consumption and Growth Rate (2017-2022)
-
Figure India Somatostatin Receptor Type 4 Consumption and Growth Rate (2017-2022)
-
Figure South Korea Somatostatin Receptor Type 4 Consumption and Growth Rate (2017-2022)
-
Figure Global Somatostatin Receptor Type 4 Consumption Forecast by Country (2022-2028)
-
Figure United States Somatostatin Receptor Type 4 Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Somatostatin Receptor Type 4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Somatostatin Receptor Type 4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Somatostatin Receptor Type 4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Somatostatin Receptor Type 4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Somatostatin Receptor Type 4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CNTX-0290 Consumption and Growth Rate (2017-2022)
-
Figure Global NNC-26910 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Cognitive Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Neuroendocrine Tumors Consumption and Growth Rate (2017-2022)
-
Figure Global Acromegaly Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global CNTX-0290 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NNC-26910 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cognitive Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neuroendocrine Tumors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acromegaly Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Somatostatin Receptor Type 4 Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Somatostatin Receptor Type 4 Export by Region (Top 5 Countries) (2017-2028)
-
Table Strongbridge Biopharma plc (Foundation Year, Company Profile and etc.)
-
Table Strongbridge Biopharma plc Somatostatin Receptor Type 4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Strongbridge Biopharma plc Somatostatin Receptor Type 4 Product and Service
-
Table Crinetics Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 4 Product and Service
-
